Gilead Sciences Inc
NASDAQ: GILD
$90.49
+$0.30 (+0.3%)
Closing Price on November 25, 2024
GILD Articles
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
These five top picks from the RBC all make sense for growth investors looking to move to companies with more reasonable valuations.
Published:
Last Updated:
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
Published:
Last Updated:
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in...
Published:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
These four health care stocks look like solid picks for the fourth quarter and into 2020. They are also favorite picks from Raymond James analysts.
Published:
Last Updated:
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Last Updated:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
Last Updated:
These five Raymond James analyst favorite stock picks have substantial upside potential to the price targets and would make solid portfolio additions at current price levels.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated: